Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Entelos has announced that it is extending its technology applications to conduct research using 'virtual consumers' for an undisclosed customer in Switzerland.
Subscribe to our email newsletter
This multi-million dollar research contract will focus on risk assessment and reduction in cardiovascular disease and other disease areas of interest to the customer. Entelos will receive technology license fees and R&D funding for the next three years.
James Karis, president and CEO of Entelos, said: “In this new application, we will be expanding its use to test the effects of ‘virtual products’ on ‘virtual consumers’, representations of unique genetic, biologic, and lifestyle profiles. We can then use our technology to optimize product designs to improve human health.”